These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20825985)

  • 1. Celiprolol therapy for vascular Ehlers-Danlos syndrome.
    Brooke BS
    Lancet; 2010 Oct; 376(9751):1443-4. PubMed ID: 20825985
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial.
    Ong KT; Perdu J; De Backer J; Bozec E; Collignon P; Emmerich J; Fauret AL; Fiessinger JN; Germain DP; Georgesco G; Hulot JS; De Paepe A; Plauchu H; Jeunemaitre X; Laurent S; Boutouyrie P
    Lancet; 2010 Oct; 376(9751):1476-84. PubMed ID: 20825986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome.
    Baderkhan H; Wanhainen A; Stenborg A; Stattin EL; Björck M
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):326-331. PubMed ID: 33223285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Boutouyrie P
    Therapie; 2020 Apr; 75(2):175-181. PubMed ID: 32127191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on "Current concepts in the diagnosis and management of vascular Ehlers-Danlos syndrome".
    Ellison J
    Perspect Vasc Surg Endovasc Ther; 2006 Sep; 18(3):215-6. PubMed ID: 17172534
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
    Gorosabel MC; Dubacher N; Meienberg J; Matyas G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):199-200. PubMed ID: 31693161
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous coronary artery dissection in Ehlers-Danlos syndrome.
    Hampole CV; Philip F; Shafii A; Pettersson G; Anesi GL; Patel JB; Menon V
    Ann Thorac Surg; 2011 Nov; 92(5):1883-4. PubMed ID: 22051286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome.
    Dubacher N; Münger J; Gorosabel MC; Crabb J; Ksiazek AA; Caspar SM; Bakker ENTP; van Bavel E; Ziegler U; Carrel T; Steinmann B; Zeisberger S; Meienberg J; Matyas G
    Cardiovasc Res; 2020 Feb; 116(2):457-465. PubMed ID: 31056650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications.
    Beridze N; Frishman WH
    Cardiol Rev; 2012; 20(1):4-7. PubMed ID: 22143279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New treatment options for vascular Ehlers-Danlos syndrome].
    Björck M; Hägg A; Wanhainen A; Pigg MH; Bergqvist D
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1354-5. PubMed ID: 23980448
    [No Abstract]   [Full Text] [Related]  

  • 11. Varying presentations in patients with symptomatic type IV vascular Ehlers-Danlos syndrome.
    Dwivedi AJ; Hamdallah O; Morris ME; Yancey AE; Ross CB
    Vasc Endovascular Surg; 2012 Feb; 46(2):163-6. PubMed ID: 22308214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal vascular catastrophe in Ehlers-Danlos syndrome: a case report and review.
    Wimmer PJ; Howes DS; Rumoro DP; Carbone M
    J Emerg Med; 1996; 14(1):25-31. PubMed ID: 8655934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Ehlers-Danlos syndrome presenting as rapidly progressive multiple arterial aneurysms and dissections.
    Mortani Barbosa EJ; Pyeritz RE; Litt H; Desjardins B
    Am J Med Genet A; 2011 Dec; 155A(12):3090-4. PubMed ID: 22065459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ehlers-Danlos Syndrome Type IV: A Case Report.
    Soo-Hoo S; Porten BR; Engstrom BI; Skeik N
    Vasc Endovascular Surg; 2016 Apr; 50(3):156-9. PubMed ID: 26975607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular Ehlers-Danlos syndrome: a clinical syndrome to be known by every anaesthesiologist and intensive care physician].
    Fèvre MC; Falcon D; Jouk PS; Seinturier C; Jacquot C
    Ann Fr Anesth Reanim; 2008 Jan; 27(1):90-3. PubMed ID: 18068944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous ruptured dissection of the right common iliac artery in a patient with classic Ehlers-Danlos syndrome phenotype.
    Gaines R; Tinkle BT; Halandras PM; Al-Nouri O; Crisostomo P; Cho JS
    Ann Vasc Surg; 2015 Apr; 29(3):595.e11-4. PubMed ID: 25597651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted dermal ultrastructural clues for Ehlers-Danlos syndrome with arterial rupture and type I collagen R-to-C substitution.
    Hermanns-Lê T; Piérard GE
    Am J Dermatopathol; 2007 Oct; 29(5):449-51. PubMed ID: 17890912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Arterial Dissections in a Patient With Vascular Ehlers-Danlos Syndrome Caused by a Frameshift Mutation in COL3A1.
    Yagyu T; Ida K; Noguchi T; Yasuda S
    Circ J; 2019 Oct; 83(11):2324. PubMed ID: 31080229
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneously ruptured splenic aneurysm in a young patient with Ehlers-Danlos syndrome.
    Rattay T; Shrivastava A; Higman DJ; Francombe J
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22700605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular-type Ehlers-Danlos syndrome presenting as recurrent compartment syndrome.
    Yoshimura Y; Nishijima C; Ikeda K; Ikeda K; Niida Y; Inaoki M
    Eur J Dermatol; 2011; 21(6):1022-3. PubMed ID: 21982893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.